Fibroblast growth factor 19 and 7α-hydroxy-4-cholesten-3-one in the diagnosis of patients with possible bile acid diarrhea

Clinical and Translational Gastroenterology

Volumn 3, Issue , 2012, Pages

  Pattni, Sanjeev S ^a   Brydon, W Gordon ^b   Dew, Tracy ^c   Walters, Julian R F ^a  

^a IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

7ALPHA HYDROXYCHOLEST 4 EN 3 ONE; BILE ACID; CHOLEST 4 EN 3 ONE; FIBROBLAST GROWTH FACTOR 19; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; BILE ACID DIARRHEA; BILE ACID SYNTHESIS; BLOOD SAMPLING; CHRONIC DIARRHEA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIARRHEA; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

EID: 84864459266     PISSN: None     EISSN: 2155384X     Source Type: Journal    
DOI: 10.1038/ctg.2012.10     Document Type: Article

References (43)

1. Pattni SS, Walters JRF. Recent advances in the understanding of bile acid malabsorption. Br Med Bull 2009; 92: 79-93.
2. Mekhjian HS, Phillips SF, Hofmann AF. Colonic secretion of water and electrolytes induced by bile acids: Perfusion studies in man. J Clin Invest 1971; 50: 1569-1577.
3. Dharmsathaphorn K, Huott PA, Vongkovit P et al. Cl- secretion induced by bile salts. A study of the mechanism of action based on a cultured colonic epithelial cell line. J Clin Invest 1989; 84: 945-953.
4. Keely SJ, Scharl MM, Bertelsen LS et al. Bile acid-induced secretion in polarized monolayers of T84 colonic epithelial cells: Structure-activity relationships. Am J Physiol Gastrointest Liver Physiol 2007; 292: G290-G297.
5. Bajor A, Ung KA, Ohman L et al. Indirect evidence for increased mechanosensitivity of jejunal secretomotor neurones in patients with idiopathic bile acid malabsorption. Acta Physiol (Oxf) 2009; 197: 129-137.
6. Bajor A, Gillberg PG, Abrahamsson H. Bile acids: Short and long term effects in the intestine. Scand J Gastroenterol 2010; 45: 645-664.
7. Hofmann AF, Poley JR. Cholestyramine treatment of diarrhea associated with ileal resection. N Engl J Med 1969; 281: 397-402.
8. Walters JRF, Pattni SS. Managing bile acid diarrhoea. Therap Adv Gastroenterol 2010; 3: 349-357.
9. Hofmann AF. Bile acids: Trying to understand their chemistry and biology with the hope of helping patients. Hepatology 2009; 49: 1403-1418.
10. Hofmann AF. The syndrome of ileal disease and the broken enterohepatic circulation: Cholerheic enteropathy. Gastroenterology 1967; 52: 752-757.
11. Fromm H, Malavolti M. Bile acid-induced diarrhoea. Clin Gastroenterol 1986; 15: 567-582.
12. Thaysen EH, Pedersen L. Idiopathic bile acid catharsis. Gut 1976; 17: 965-970.
13. Thomas PD, Forbes A, Green J et al. Guidelines for the investigation of chronic diarrhoea 2nd edition. Gut 2003; 52 (Suppl 5): V1-15.
14. Spiller RC, Thompson WG. Bowel disorders. Am J Gastroenterol 2010; 105: 775-785.
15. Khalid U, Lalji A, Stafferton R, Andreyev J. Bile acid malabsorption: A forgotten diagnosis? Clin Med 2010; 10: 124-126.
16. Wedlake L, Aohern R, Thomas K, Walters JRF, Andreyev HJN. Systematic review: The prevalence of idiopathic bile acid malabsorption (I-BAM) as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome (IBS). Aliment Pharmacol Ther 2009; 30: 707-717.
17. Walters JR. Defining primary bile acid diarrhea: Making the diagnosis and recognizing the disorder. Expert Rev Gastroenterol Hepatol 2010; 4: 561-567.
18. Boyd GS, Merrick MV, Monks R, Thomas IL. Se-75-labeled bile acid analogs, new radiopharmaceuticals for investigating the enterohepatic circulation. J Nucl Med 1981; 22: 720-725.
19. Bajor A, Kilander A, Sjovall H, Rudling M, Ung KA. The bile acid turnover rate assessed with the (75)SeHCAT test is stable in chronic diarrhoea but slightly decreased in healthy subjects after a long period of time. Dig Dis Sci 2008; 53: 2935-2940.
20. Axelson M, Aly A, Sjovall J. Levels of 7 alpha-hydroxy-4-cholesten-3-one in plasma reflect rates of bile acid synthesis in man. FEBS Lett 1988; 239: 324-328.
21. Galman C, Arvidsson I, Angelin B, Rudling M. Monitoring hepatic cholesterol 7alphahydroxylase activity by assay of the stable bile acid intermediate 7alpha-hydroxy-4- cholesten-3-one in peripheral blood. J Lipid Res 2003; 44: 859-866.
22. Song KH, Li T, Owsley E, Strom S, Chiang JY. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression. Hepatology 2009; 49: 297-305.
23. Eusufzai S, Axelson M, Angelin B, Einarsson K. Serum 7 alpha-hydroxy-4-cholesten-3-one concentrations in the evaluation of bile acid malabsorption in patients with diarrhoea: Correlation to SeHCAT test. Gut 1993; 34: 698-701.
24. Brydon WG, Nyhlin H, Eastwood MA, Merrick MV. Serum 7 alpha-hydroxy-4-cholesten-3- one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur J Gastroenterol Hepatol 1996; 8: 117-123.
25. Sauter GH, Munzing W, von RC, Paumgartner G. Bile acid malabsorption as a cause of chronic diarrhea: Diagnostic value of 7alpha-hydroxy-4-cholesten-3-one in serum. Dig Dis Sci 1999; 44: 14-19.
26. Camilleri M, Nadeau A, Tremaine WJ et al. Measurement of serum 7alpha-hydroxy-4- cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry. Neurogastroenterol Motil 2009; 21: 734-e43.
27. Walters JRF, Tasleem AM, Omer OS et al. A new mechanism for bile acid diarrhea: Defective feedback inhibition of bile acid biosynthesis. Clin Gastroenterol Hepatol 2009; 7: 1189-1194.
28. Hofmann AF, Mangelsdorf DJ, Kliewer SA. Chronic diarrhea due to excessive bile acid synthesis and not defective ileal transport: A new syndrome of defective fibroblast growth factor 19 release. Clin Gastroenterol Hepatol 2009; 7: 1151-1154.
29. Brydon WG, Culbert P, Kingstone K et al. An evaluation of the use of serum 7-alphahydroxycholestenone as a diagnostic test of bile acid malabsorption causing watery diarrhea. Can J Gastroenterol 2011; 25: 319-323.
30. Honda A, Yamashita K, Numazawa M et al. Highly sensitive quantification of 7alphahydroxy- 4-cholesten-3-one in human serum by LC-ESI-MS/MS. J Lipid Res 2007; 48: 458-464.
31. Axelson M, Mork B, Sjovall J. Ethanol has an acute effect on bile acid biosynthesis in man. FEBS Lett 1991; 281: 155-159.
32. Duane WC. Abnormal bile acid absorption in familial hypertriglyceridemia. J Lipid Res 1995; 36: 96-107.
33. Galman C, Angelin B, Rudling M. Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis. Gastroenterology 2005; 129: 1445-1453.
34. Pooler PA, Duane WC. Effects of bile acid administration on bile acid synthesis and its circadian rhythm in man. Hepatology 1988; 8: 1140-1146.
35. Lundasen T, Galman C, Angelin B, Rudling M. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. J Intern Med 2006; 260: 530-536.
36. Stejskal D, Karpisek M, Hanulova Z, Stejskal P. Fibroblast growth factor-19: Development, analytical characterization and clinical evaluation of a new ELISA test. Scand J Clin Lab Invest 2008; 68: 501-507.
37. Kuganolipava S, Dew T, Pattni SS et al. Rapid normalisation of fasting serum fibroblast growth factor (FGF) 19 following bariatric surgery. Gut 2009; 58 (Suppl II): A121.
38. Sadik R, Abrahamsson H, Ung K-A, Stotzer P-O. Accelerated regional bowel transit and overweight shown in idiopathic bile acid malabsorption. Am J Gastroenterol 2004; 99: 711-718.
39. Galman C, Angelin B, Rudling M. Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19. J Intern Med 2011; 270: 580-588.
40. Schaap FG, van der Gaag NA, Gouma DJ, Jansen PL. High expression of the bile salthomeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis. Hepatology 2009; 49: 1228-1235.
41. Zweers SJ, Booij KA, Komuta M et al. The human gallbladder secretes fibroblast growth factor 19 into bile: Towards defining the role of fibroblast growth factor 19 in the enterobiliary tract. Hepatology 2011; 55: 575-583.
42. Yu C, Wang F, Jin C, Huang X, McKeehan WL. Independent repression of bile acid synthesis and activation of c-Jun N-terminal kinase (JNK) by activated hepatocyte fibroblast growth factor receptor 4 (FGFR4) and bile acids. J Biol Chem 2005; 280: 17707-17714.
43. Wong BS, Camilleri M, Carlson PJ et al. A Klotho-beta variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea. Gastroenterology 2011; 140: 1934-1942.